Elevance Health Inc (ELV)

Currency in USD
410.95
-3.31(-0.80%)
Closed·
410.950.00(0.00%)
·

ELV Earnings

Latest Release
Jul 15, 2026
EPS / Forecast
7.45 / 6.21
Revenue / Forecast
49.8B / 48.63B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/4.66--/49.26B----Free Sign Up
2026/067.45/6.2149.80B/48.63B+19.97%+2.41%Free Sign Up
2026/0312.58/10.8449.50B/48.20B+16.05%+2.7%Free Sign Up
2025/123.33/3.1049.30B/49.82B+7.42%-1.04%Free Sign Up
2025/096.03/4.9550.09B/49.34B+21.82%+1.52%Free Sign Up
2025/068.84/9.0749.42B/48.14B-2.54%+2.66%Free Sign Up
2025/0311.97/11.0848.80B/46.27B+8.03%+5.47%Free Sign Up
2024/123.84/3.9845.00B/44.90B-3.52%+0.22%Free Sign Up
2024/098.37/9.6644.70B/43.46B-13.35%+2.85%Free Sign Up
2024/0610.12/10.0143.22B/43.05B+1.1%+0.39%Free Sign Up

All numbers in USD

Elevance Health Inc Earnings Call Summary for Q2/2026

  • Elevance Health Q2 2026 adjusted EPS of $7.45 beat estimates by 20%; revenue of $49.8B topped forecasts, but shares fell 10.58% to $381.62.
  • Company raised full-year 2026 EPS guidance to at least $27.00 and operating cash flow outlook to at least $6.0B from prior expectations.
  • Medicaid remains weakest segment with -1.75% operating margin expected for 2026; firm plans to exit additional markets over next 12-18 months.
  • Quarter included $0.80 per share one-time benefit from investment income adjustments, which will fund accelerated investments in second half.
  • Management expects return to at least 12% adjusted EPS growth in 2027 from baseline of $26.00, citing Medicare Advantage improvement and Carelon growth.
Last Updated: 2026-07-15, 10:52 a/m
Read Full Transcript

FAQ

What Is Elevance Health's Earnings Per Share (TTM)?

The Elevance Health EPS (TTM) is 22.47.

When Is The Next Elevance Health Earnings Date?

Elevance Health will release its next earnings report on Oct 21, 2026.

What Is Elevance Health’s Revenue Forecasts For Upcoming Quarters?

Elevance Health’s revenue forecast is 49.26B.

How Did Elevance Health React to the Company's Latest Earnings Report?

Elevance Health reported a +19.97% EPS surprise and a +2.41% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -12.64%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.